The Effect of Hypoxia on Relative Biological Effectiveness and Oxygen Enhancement Ratio for Cells Irradiated with Grenz Rays.
Chan CC, Chen FH, Hsueh KL, Hsiao YY.
Cancers (Basel). 2022 Feb 28;14(5):1262. doi: 10.3390/cancers14051262.
Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
Paganetti H.
Phys Med Biol. 2014 Nov 21;59(22):R419-72. doi: 10.1088/0031-9155/59/22/R419. Epub 2014 Oct 31.
Relative Biological Effectiveness (RBE) of [(64)Cu]Cu and [(177)Lu]Lu-NOTA-panitumumab F (ab')(2) radioimmunotherapeutic agents vs. gamma-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells.
Boyle AJ, Cai Z, O'Brien S, Crick J, Angers S, Reilly RM.
Nucl Med Biol. 2023 Jul-Aug;122-123:108367. doi: 10.1016/j.nucmedbio.2023.108367. Epub 2023 Jul 17.
A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE).
Underwood TSA, McNamara AL, Appelt A, Haviland JS, Sørensen BS, Troost EGC.
Radiother Oncol. 2022 Oct;175:79-92. doi: 10.1016/j.radonc.2022.08.014. Epub 2022 Aug 18.
Relative biological effectiveness (RBE) values for proton beam therapy.
Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, Suit HD.
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):407-21. doi: 10.1016/s0360-3016(02)02754-2.
A comparison of mechanism-inspired models for particle relative biological effectiveness (RBE).
Stewart RD, Carlson DJ, Butkus MP, Hawkins R, Friedrich T, Scholz M.
Med Phys. 2018 Nov;45(11):e925-e952. doi: 10.1002/mp.13207.
Fundamental space radiobiology.
Nelson GA.
Gravit Space Biol Bull. 2003 Jun;16(2):29-36.
The physical separation between the LET associated with the ultimate relative biological effect (RBE) and the maximum LET in a proton or ion beam.
Jones B, Hill MA.
Biomed Phys Eng Express. 2020 Jul 7;6(5):055001. doi: 10.1088/2057-1976/ab9e13.
First in vitro measurement of VHEE relative biological effectiveness (RBE) in lung and prostate cancer cells using the ARES linac at DESY.
Wanstall HC, Burkart F, Dinter H, Kellermeier M, Kuropka W, Mayet F, Vinatier T, Santina E, Chadwick AL, Merchant MJ, Henthorn NT, Köpke M, Stacey B, Jaster-Merz S, Jones RM.
Sci Rep. 2024 May 13;14(1):10957. doi: 10.1038/s41598-024-60585-7.
Modelling variable proton relative biological effectiveness for treatment planning.
McNamara A L, Willers H, Paganetti H.
Br J Radiol. 2020 Mar;93(1107):20190334. doi: 10.1259/bjr.20190334. Epub 2019 Nov 18.
